This is a StreetInsider.com Premium Only Page

Gilead Sciences (GILD) – Major News

Feb 6, 2024 04:04 PM Gilead Sciences (GILD) Misses Q4 EPS by 4c; offers guidance

Nov 7, 2023 04:03 PM Gilead Sciences (GILD) Tops Q3 EPS by 38c, Offers Guidance

Aug 3, 2023 04:04 PM Gilead Sciences (GILD) Misses Q2 EPS by 31c; offers guidance

Apr 27, 2023 04:04 PM Gilead Sciences (GILD) Misses Q1 EPS by 16c, Revenues Beat; Guides Revenue Below

Feb 2, 2023 04:06 PM Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides

Oct 27, 2022 04:01 PM Gilead Sciences (GILD) Tops Q3 EPS by 38c

Aug 2, 2022 04:03 PM Gilead Sciences (GILD) Tops Q2 EPS by 6c, Offers Guidance

Apr 28, 2022 04:05 PM Gilead Sciences (GILD) Tops Q1 EPS by 31c

Feb 1, 2022 04:04 PM Gilead Sciences (GILD) Misses Q4 EPS by 83c; Offers 2022 Guidance

Oct 28, 2021 04:04 PM Gilead Sciences (GILD) Tops Q3 EPS by 94c

Jul 29, 2021 04:05 PM Gilead Sciences (GILD) Tops Q2 EPS by 14c

Apr 29, 2021 04:02 PM Gilead Sciences (GILD) Misses Q1 EPS by 1c

Feb 4, 2021 04:03 PM Gilead Sciences (GILD) Tops Q4 EPS by 4c, Offers FY Guidance

Oct 28, 2020 04:04 PM Gilead Sciences (GILD) Tops Q3 EPS by 16c, Remdesivir Revenue $873M in Qtr; Lowers FY EPS Guidance

Sep 13, 2020 08:03 PM Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion

Sep 12, 2020 03:17 PM Gilead (GILD) Near Deal to Acquire Immunomedics (IMMU) for More than $20B - WSJ

Jul 30, 2020 04:03 PM Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line

May 1, 2020 03:51 PM Gilead Sciences' (GILD) Remdesivir Receives FDA Emergency Use Authorization For COVID-19

Apr 30, 2020 04:07 PM Gilead Sciences (GILD) Tops Q1 EPS by 11c

Apr 29, 2020 08:30 AM Gilead (GILD) Says NIAID Study of Investigational Antiviral Remdesivir for COVID-19 Met Its Primary Endpoint

Apr 11, 2020 10:48 AM Gilead Sciences (GILD) Remdesivir Study Shows Two-Third of Severe COVID-19 Patients Improved

Mar 2, 2020 06:56 AM Gilead (GILD) to Acquire Forty Seven (FTSV) for $4.9 Billion, $95.50/Share in Cash

Feb 4, 2020 04:03 PM Gilead Sciences (GILD) Misses Q4 EPS by 37c, Offers Guidance

Feb 3, 2020 06:25 AM Gilead Sciences (GILD) Shares Surges as Remdesivir May Be Effective in Treating Coronavirus

Oct 24, 2019 04:03 PM Gilead Sciences (GILD) Tops Q3 EPS by 1c

Jul 30, 2019 04:04 PM Gilead Sciences (GILD) Tops Q2 EPS by 10c, Revises FY Guidance

Jul 14, 2019 04:13 PM Gilead (GILD) Expands Collaboration with Galapagos (GLPG), Raises Stake to 22%

May 2, 2019 04:02 PM Gilead Sciences (GILD) Tops Q1 EPS by 15c, Reiterate Guidance

Feb 4, 2019 04:02 PM Gilead Sciences (GILD) Misses Q4 EPS by 27c, Offers FY Guidance

Oct 25, 2018 04:06 PM Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance

Jul 25, 2018 04:02 PM Gilead Sciences (GILD) Tops Q2 EPS by 35c

Jul 25, 2018 04:01 PM Gilead Sciences (GILD) CEO John F. Milligan to Step Down

May 1, 2018 04:02 PM Gilead Sciences (GILD) Misses Q1 EPS by 19c, Reiterates FY Guidance

Feb 6, 2018 04:03 PM Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance

Oct 26, 2017 04:04 PM Gilead Sciences (GILD) Tops Q3 EPS by 14c

Oct 18, 2017 05:46 PM Gilead Sciences (GILD) Announces Kite's Yescarta Becomes First CAR T Therapy Approved by FDA for Treatment of Adult Patients With R/R Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy

Oct 16, 2017 06:32 AM Sprint (S) Expands Contract with Gilat Satellite (GILT)

Aug 28, 2017 07:01 AM Gilead Sciences (GILD) Announces Agreement to Acquire Kite Pharma (KITE) for $11.9B

Aug 28, 2017 06:39 AM Gilead Sciences (GILD) to Acquire Kite Pharma (KITE) for About $11B - WSJ

Jul 26, 2017 04:05 PM Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance

May 2, 2017 04:02 PM Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance

Mar 10, 2017 03:18 PM Gilead (GILD) Said Close to Pulling Trigger on Incyte (INCY) Takeover - Source

Feb 7, 2017 04:03 PM Gilead Sciences (GILD) Tops Q4 EPS by 9c, Offers FY17 Guidance

Nov 1, 2016 04:03 PM Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

Jul 25, 2016 04:09 PM Gilead Sciences (GILD) Tops Q2 EPS by 6c

Apr 28, 2016 04:05 PM Gilead Sciences (GILD) Misses Q1 EPS by 10c

Feb 2, 2016 04:00 PM Gilead Sciences (GILD) Tops Q4 EPS by 32c

Jan 29, 2016 08:17 AM Gilead Sciences (GILD) Names John Milligan CEO

Oct 27, 2015 04:02 PM Gilead Sciences (GILD) Tops Q3 EPS by 33c, Updates FY15 Guidance

Jul 28, 2015 04:02 PM Gilead Sciences (GILD) Tops Q2 EPS by 44c